+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celldex Therapeutics, Inc.  - logo

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

From
Global Cholera Vaccines Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Cholera Vaccines Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Breast Cancer Monoclonal Antibodies Global Market Report 2024 - Product Thumbnail Image

Breast Cancer Monoclonal Antibodies Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Global Throat Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Throat Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 158 Pages
  • Global
From
Global Laryngeal Cancer Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Laryngeal Cancer Therapeutics Market 2023-2027

  • Report
  • October 2023
  • 162 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 1722 Pages
  • Global
From
Bladder Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1855 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 Pages
  • Global
From
Loading Indicator